Clinical Trials Browser

Terminated × Carcinoma × Sorafenib × Clear all

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00576056 2017-02-15

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Phase 2 Terminated

19 enrolled 7 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT01009593 2012-09-10

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1,035 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Clinical Trials

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)